Guardant Health, Inc. (GH) financial statements and ratios from SEC XBRL: revenue $1.2B (TTM), net margin -42.4%, revenue growth 44.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $982.02M |
| Revenue (TTM) | $1.2B |
| Net Margin | -42.4% |
| Operating Margin (TTM) | -39.7% |
| Net Debt / EBITDA | -0.8 |
| Revenue Growth (YoY) | 44.3% |
| EPS Growth (YoY) | 12.5% |
| FCF Growth (YoY) | 5.5% |
| Price / Sales | 18.70 |
| FCF Yield | -1.1% |
| Altman Z-Score | 4.52 (safe) |
| Piotroski F-Score | 5/9 |
| Piotroski checks passed | 5 of 9 |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
GH overview · GH earnings · GH KPIs · GH documents · GH ownership · GH peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.